Feasibility Phase 2 Study of Psilocybin-Assisted Therapy for Opioid-Refractory Pain in Patients With Advanced Cancer

Phase: PHASE2 | Sponsor: Yvan Beaussant, MD, MSci | Compound: Psilocybin

Status

recruiting

Institution

Yvan Beaussant, MD, MSci

Start date

2024-09-23

End date

2026-12-31

Registry ID

NCT06001749

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.